Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
AmBisome - labeled renal guidance
Product / population
Liposomal amphotericin B (AmBisome), adult IV infusion
Renal method
Clinical renal category or population named in the cited section
Source revision
DailyMed SPL version 14, effective 2026-10-02; posted Oct 05, 2026
DailyMed / product prescribing information · Liposomal amphotericin B (AmBisome), adult IV infusion
Renal method: Clinical renal category or population named in the cited section Source date: DailyMed SPL version 14, effective 2026-10-02; posted Oct 05, 2026 Retrieved: 2026-11-07
Limited or unstudied renal evidence. Not studied does not mean no adjustment is required.
Renal guidance: Clinical pharmacology, special populations; laboratory tests
The label describes use in patients with pre-existing impairment, but the effect of renal impairment on drug disposition has not been studied. Check kidney function and electrolytes, including potassium and magnesium. Confirm the liposomal formulation before use.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
